BioCentury
ARTICLE | Company News

Biotrin Holdings plc, Meridian Bioscience deal

May 28, 2002 7:00 AM UTC

Diagnostics company VIVO signed a letter of intent to acquire Biotrin, a developer of predictive toxicology tools and parvovirus diagnostics, for an undisclosed sum. Biotrin has about $7 million in an...